These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 9382472)

  • 1. Huntingtin localization in brains of normal and Huntington's disease patients.
    Sapp E; Schwarz C; Chase K; Bhide PG; Young AB; Penney J; Vonsattel JP; Aronin N; DiFiglia M
    Ann Neurol; 1997 Oct; 42(4):604-12. PubMed ID: 9382472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Huntington aggregates may not predict neuronal death in Huntington's disease.
    Kuemmerle S; Gutekunst CA; Klein AM; Li XJ; Li SH; Beal MF; Hersch SM; Ferrante RJ
    Ann Neurol; 1999 Dec; 46(6):842-9. PubMed ID: 10589536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Axonal transport of N-terminal huntingtin suggests early pathology of corticostriatal projections in Huntington disease.
    Sapp E; Penney J; Young A; Aronin N; Vonsattel JP; DiFiglia M
    J Neuropathol Exp Neurol; 1999 Feb; 58(2):165-73. PubMed ID: 10029099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain.
    DiFiglia M; Sapp E; Chase KO; Davies SW; Bates GP; Vonsattel JP; Aronin N
    Science; 1997 Sep; 277(5334):1990-3. PubMed ID: 9302293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Huntington's disease intranuclear inclusions contain truncated, ubiquitinated huntingtin protein.
    Sieradzan KA; Mechan AO; Jones L; Wanker EE; Nukina N; Mann DM
    Exp Neurol; 1999 Mar; 156(1):92-9. PubMed ID: 10192780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased calbindin-D28k immunoreactivity in striatal projection neurons of R6/2 Huntington's disease transgenic mice.
    Sun Z; Wang HB; Deng YP; Lei WL; Xie JP; Meade CA; Del Mar N; Goldowitz D; Reiner A
    Neurobiol Dis; 2005 Dec; 20(3):907-17. PubMed ID: 15990326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Huntingtin immunoreactivity in the rat neostriatum: differential accumulation in projection and interneurons.
    Kosinski CM; Cha JH; Young AB; Persichetti F; MacDonald M; Gusella JF; Penney JB; Standaert DG
    Exp Neurol; 1997 Apr; 144(2):239-47. PubMed ID: 9168825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Huntingtin aggregate-associated axonal degeneration is an early pathological event in Huntington's disease mice.
    Li H; Li SH; Yu ZX; Shelbourne P; Li XJ
    J Neurosci; 2001 Nov; 21(21):8473-81. PubMed ID: 11606636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mass Spectrometry Analysis of Wild-Type and Knock-in Q140/Q140 Huntington's Disease Mouse Brains Reveals Changes in Glycerophospholipids Including Alterations in Phosphatidic Acid and Lyso-Phosphatidic Acid.
    Vodicka P; Mo S; Tousley A; Green KM; Sapp E; Iuliano M; Sadri-Vakili G; Shaffer SA; Aronin N; DiFiglia M; Kegel-Gleason KB
    J Huntingtons Dis; 2015; 4(2):187-201. PubMed ID: 26397899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cortical efferents lacking mutant huntingtin improve striatal neuronal activity and behavior in a conditional mouse model of Huntington's disease.
    Estrada-Sánchez AM; Burroughs CL; Cavaliere S; Barton SJ; Chen S; Yang XW; Rebec GV
    J Neurosci; 2015 Mar; 35(10):4440-51. PubMed ID: 25762686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutant huntingtin and glycogen synthase kinase 3-beta accumulate in neuronal lipid rafts of a presymptomatic knock-in mouse model of Huntington's disease.
    Valencia A; Reeves PB; Sapp E; Li X; Alexander J; Kegel KB; Chase K; Aronin N; DiFiglia M
    J Neurosci Res; 2010 Jan; 88(1):179-90. PubMed ID: 19642201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha-synuclein immunoreactivity of huntingtin polyglutamine aggregates in striatum and cortex of Huntington's disease patients and transgenic mouse models.
    Charles V; Mezey E; Reddy PH; Dehejia A; Young TA; Polymeropoulos MH; Brownstein MJ; Tagle DA
    Neurosci Lett; 2000 Jul; 289(1):29-32. PubMed ID: 10899401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of inclusions in neuronal nuclei and dystrophic neurites in Huntington disease brain.
    Maat-Schieman ML; Dorsman JC; Smoor MA; Siesling S; Van Duinen SG; Verschuuren JJ; den Dunnen JT; Van Ommen GJ; Roos RA
    J Neuropathol Exp Neurol; 1999 Feb; 58(2):129-37. PubMed ID: 10029096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential distribution of the normal and mutated forms of huntingtin in the human brain.
    Gourfinkel-An I; Cancel G; Trottier Y; Devys D; Tora L; Lutz Y; Imbert G; Saudou F; Stevanin G; Agid Y; Brice A; Mandel JL; Hirsch EC
    Ann Neurol; 1997 Nov; 42(5):712-9. PubMed ID: 9392570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Huntingtin expression stimulates endosomal-lysosomal activity, endosome tubulation, and autophagy.
    Kegel KB; Kim M; Sapp E; McIntyre C; Castaño JG; Aronin N; DiFiglia M
    J Neurosci; 2000 Oct; 20(19):7268-78. PubMed ID: 11007884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue-specific proteolysis of Huntingtin (htt) in human brain: evidence of enhanced levels of N- and C-terminal htt fragments in Huntington's disease striatum.
    Mende-Mueller LM; Toneff T; Hwang SR; Chesselet MF; Hook VY
    J Neurosci; 2001 Mar; 21(6):1830-7. PubMed ID: 11245667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular and subcellular localization of Huntingtin [corrected] aggregates in the brain of a rat transgenic for Huntington disease.
    Petrasch-Parwez E; Nguyen HP; Löbbecke-Schumacher M; Habbes HW; Wieczorek S; Riess O; Andres KH; Dermietzel R; Von Hörsten S
    J Comp Neurol; 2007 Apr; 501(5):716-30. PubMed ID: 17299753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The selective vulnerability of nerve cells in Huntington's disease.
    Sieradzan KA; Mann DM
    Neuropathol Appl Neurobiol; 2001 Feb; 27(1):1-21. PubMed ID: 11298997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in cortical and striatal neurons predict behavioral and electrophysiological abnormalities in a transgenic murine model of Huntington's disease.
    Laforet GA; Sapp E; Chase K; McIntyre C; Boyce FM; Campbell M; Cadigan BA; Warzecki L; Tagle DA; Reddy PH; Cepeda C; Calvert CR; Jokel ES; Klapstein GJ; Ariano MA; Levine MS; DiFiglia M; Aronin N
    J Neurosci; 2001 Dec; 21(23):9112-23. PubMed ID: 11717344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cellular and subcellular localization of huntingtin-associated protein 1 (HAP1): comparison with huntingtin in rat and human.
    Gutekunst CA; Li SH; Yi H; Ferrante RJ; Li XJ; Hersch SM
    J Neurosci; 1998 Oct; 18(19):7674-86. PubMed ID: 9742138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.